The hypoxia-inducible factor-1α activates ectopic production of fibroblast growth factor 23 in tumor-induced osteomalacia
Open Access
- 5 July 2016
- journal article
- Published by Springer Nature in Bone Research
- Vol. 4 (1) , 16011
Abstract
Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome in which ectopic production of fibroblast growth factor 23 (FGF23) by non-malignant mesenchymal tumors causes phosphate wasting and bone fractures. Recent studies have implicated the hypoxia-inducible factor-1α (HIF-1α) in other phosphate wasting disorders caused by elevated FGF23, including X-linked hypophosphatemic rickets and autosomal dominant hypophosphatemia. Here we provide evidence that HIF-1α mediates aberrant FGF23 in TIO by transcriptionally activating its promoter. Immunohistochemical studies in phosphaturic mesenchymal tumors resected from patients with documented TIO showed that HIF-1α and FGF23 were co-localized in spindle-shaped cells adjacent to blood vessels. Cultured tumor tissue produced high levels of intact FGF23 and demonstrated increased expression of HIF-1α protein. Transfection of MC3T3-E1 and Saos-2 cells with a HIF-1α expression construct induced the activity of a FGF23 reporter construct. Prior treatment of tumor organ cultures with HIF-1α inhibitors decreased HIF-1α and FGF23 protein accumulation and inhibited HIF-1α-induced luciferase reporter activity in transfected cells. Chromatin immunoprecipitation assays confirmed binding to a HIF-1α consensus sequence within the proximal FGF23 promoter, which was eliminated by treatment with a HIF-1α inhibitor. These results show for the first time that HIF-1α is a direct transcriptional activator of FGF23 and suggest that upregulation of HIF-1α activity in TIO contributes to the aberrant FGF23 production in these patients.Keywords
This publication has 18 references indexed in Scilit:
- FGF23 and Phosphate Wasting DisordersBone Research, 2013
- Tumor-induced osteomalacia: An important cause of adult-onset hypophosphatemic osteomalacia in China: Report of 39 cases and review of the literatureJournal of Bone and Mineral Research, 2012
- Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in miceProceedings of the National Academy of Sciences, 2011
- Tumor-induced osteomalaciaEndocrine-Related Cancer, 2011
- Recent advances in renal phosphate handlingNature Reviews Nephrology, 2010
- Most Osteomalacia-associated Mesenchymal Tumors Are a Single Histopathologic EntityAmerican Journal of Surgical Pathology, 2004
- Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23Kidney International, 2001
- Tumor-Induced OsteomalaciaReviews in Endocrine and Metabolic Disorders, 2001
- HIF-1: mediator of physiological and pathophysiological responses to hypoxiaJournal of Applied Physiology, 2000
- Review and Update: Oncogenic Osteomalacia-RicketsUltrastructural Pathology, 1991